Literature DB >> 17109649

Clinical and biological consequences of transmetallation induced by contrast agents for magnetic resonance imaging: a review.

Jean-Marc Idée1, Marc Port, Isabelle Raynal, Michel Schaefer, Soizic Le Greneur, Claire Corot.   

Abstract

Gadolinium-based contrast agents (CAs) are widely used to enhance the contrast of images in magnetic resonance imaging procedures. Two categories of gadolinium chelates exist: the macrocyclic molecules where Gd3+ is caged in the pre-organized cavity of the ligand and the linear molecules. Gadolinium chelates differ in their thermodynamic stability constants and in their kinetic stability. In general, macrocyclic chelates such as Gd-DOTA or Gd-HP-DO3A are more stable than linear molecules. Even among linear agents, differences can be found. There is increasing evidence that transmetallation can be found in vivo, in the case of certain CAs (especially linear chelates), with body cations such as zinc, calcium or iron. Furthermore, analytical interference with colorimetric determination of calcium has been clinically evidenced with two linear chelates, Gd-DTPA-BMA and Gd-DTPA-BMEA. Clinical cases of spurious hypocalcaemia have been reported with these molecules. Such interference with some colorimetric assays for calcium is clinically relevant in that it can lead to unnecessary and potentially harmful treatment for hypocalcaemia.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17109649     DOI: 10.1111/j.1472-8206.2006.00447.x

Source DB:  PubMed          Journal:  Fundam Clin Pharmacol        ISSN: 0767-3981            Impact factor:   2.748


  71 in total

1.  Incorporation of in silico biodegradability screening in early drug development--a feasible approach?

Authors:  Thomas Steger-Hartmann; Reinhard Länge; Klaus Heuck
Journal:  Environ Sci Pollut Res Int       Date:  2010-10-28       Impact factor: 4.223

Review 2.  Gadolinium-based contrast agents: did we miss something in the last 25 years?

Authors:  Bruno Beomonte Zobel; Carlo Cosimo Quattrocchi; Yuri Errante; Rosario Francesco Grasso
Journal:  Radiol Med       Date:  2015-12-26       Impact factor: 3.469

3.  Gadolinium deposition in the brain: association with various GBCAs using a generalized additive model.

Authors:  Sohi Bae; Ho-Joon Lee; Kyunghwa Han; Yae-Won Park; Yoon Seong Choi; Sung Soo Ahn; Jinna Kim; Seung-Koo Lee
Journal:  Eur Radiol       Date:  2017-01-12       Impact factor: 5.315

4.  Nephrogenic systemic fibrosis is not exclusively associated with gadodiamide.

Authors:  Tim Leiner; Christoph U Herborn; Mathias Goyen
Journal:  Eur Radiol       Date:  2007-04-26       Impact factor: 5.315

Review 5.  [Nephrogenic systemic fibrosis].

Authors:  Stefan Becker; Oliver Witzke; Andreas Kribben
Journal:  Med Klin (Munich)       Date:  2009-04-01

6.  Signal intensity change on unenhanced T1-weighted images in dentate nucleus following gadobenate dimeglumine in patients with and without previous multiple administrations of gadodiamide.

Authors:  Joana Ramalho; Richard C Semelka; Mamdoh AlObaidy; Miguel Ramalho; Renato H Nunes; Mauricio Castillo
Journal:  Eur Radiol       Date:  2016-02-24       Impact factor: 5.315

7.  [Nephrogenic systemic fibrosis].

Authors:  W Samtleben
Journal:  Radiologe       Date:  2007-09       Impact factor: 0.635

8.  Risk of nephrogenic systemic fibrosis is low in patients with chronic liver disease exposed to gadolinium-based contrast agents.

Authors:  Emmanuil Smorodinsky; David S Ansdell; Zeke W Foster; Sameer M Mazhar; Irene Cruite; Tanya Wolfson; Sebastian B Sugay; Gabriella Iussich; Masoud Shiehmorteza; Yuko Kono; Alexander Kuo; Claude B Sirlin
Journal:  J Magn Reson Imaging       Date:  2014-05-09       Impact factor: 4.813

9.  Ultrastructural evidence of dermal gadolinium deposits in a patient with nephrogenic systemic fibrosis and end-stage renal disease.

Authors:  Josef A Schroeder; Christian Weingart; Brigitte Coras; Ingrid Hausser; Stephan Reinhold; Matthias Mack; Volker Seybold; Thomas Vogt; Bernhard Banas; Ferdinand Hofstaedter; Bernhard K Krämer
Journal:  Clin J Am Soc Nephrol       Date:  2008-04-02       Impact factor: 8.237

10.  Gadolinium-containing bioparticles as an active entity to promote cell cycle progression in mouse embryo fibroblast NIH3T3 cells.

Authors:  Jin-Xia Li; Jing-Cheng Liu; Kui Wang; Xiao-Gai Yang
Journal:  J Biol Inorg Chem       Date:  2010-01-14       Impact factor: 3.358

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.